<Suppliers Price>

Rostafuroxin

Names

[ CAS No. ]:
156722-18-8

[ Name ]:
Rostafuroxin

[Synonym ]:
UNII-P848LCX62B
Rostafuroxin
24-Norchola-20,22-diene-3,14,17-triol, 21,23-epoxy-, (3β,5β,14β)-
(3β,5β,14β,17α)-17-(3-Furyl)androstane-3,14,17-triol
Androstane-3,14,17-triol, 17-(3-furanyl)-, (3β,5β,14β,17α)-
PST2238

Biological Activity

[Description]:

Rostafuroxin(PST 2238) is a antihypertensive compound; Na,K-ATPase antognist;displaced [3H]ouabain from the dogkidney Na+,K+-ATPase with IC50 of 1.5 nM.IC50 value: 1.5 nM [1]Target: Na+,K+-ATPase modulator; ouabain antagonistin vitro: PST 2238 displaced [3H]ouabain from the dog kidney Na+,K+-ATPase receptor (IC50 ) 1.5X 10-6M), was devoid of cardiac inotropic activity in isolated guinea pig atria, and showed no affinity up to 10-4 M with general (R1, R2, a1, a2, A1, A2, M1, M2, H1, H2, 5-HT1, 5-HT2, Ca2+ channels, TXA2/PGH2, PAF, GABAA, GABAB, DA-NE-5-HT uptake, glutammate,glycine, benzodiazepine) and hormonal (estrogenic, progestinic, androgenic, mineralcorticoid) receptors [1]. At molecular level, in the kidney, Rostafuroxin antagonizes EO triggering of the Src-epidermal growth factor receptor (EGFr)-dependent signaling pathway leading to renal Na+-K+ pump, and ERK tyrosine phosphorylation and activation [3].in vivo: PST 2238, given orally at very low doses (1 and 10 microg/kg for 5-6 weeks), reduced the development of hypertension in MHS rats and normalized the increased renal Na,K-ATPase activity and mRNA levels, whereas it did not affect either blood pressure or Na,K-ATPase in Milan-normotensive (MNS) rats [2].

[Related Catalog]:

Signaling Pathways >> Membrane Transporter/Ion Channel >> Na+/K+ ATPase
Research Areas >> Cardiovascular Disease

[References]

[1]. Quadri L, et al. 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action. J Med Chem. 1997 May 23;40(11):1561-4.

[2]. Ferrari P, et al. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther. 1999 Mar;288(3):1074-83.

[3]. Ferrari P, et al. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R529-35.


[Related Small Molecules]

digoxin | Ouabain Octahydrate | Istaroxime (hydrochloride) | Phlorizin | Digitoxin | ginsenoside Rb1 | Oleandrin | (+)-SJ733 | Acevaltrate | Prilocaine

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
451.3±45.0 °C at 760 mmHg

[ Molecular Formula ]:
C23H34O4

[ Molecular Weight ]:
374.514

[ Flash Point ]:
226.7±28.7 °C

[ Exact Mass ]:
374.245697

[ PSA ]:
73.83000

[ LogP ]:
3.56

[ Vapour Pressure ]:
0.0±1.2 mmHg at 25°C

[ Index of Refraction ]:
1.591

[ Storage condition ]:
2-8℃

Safety Information

[ RIDADR ]:
NONH for all modes of transport